Search

everythinglearnresearchcommunity

for

Search:↓

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Apremilast did not work for treating severe alopecia areata.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

Acne can't be cured but can be managed with treatments like benzoyl peroxide and diet changes; it's costly and can lead to scarring and mental health issues.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Acanthus ebracteatus Vahl. extract and verbascoside may help prevent hair loss and promote hair growth due to their anti-inflammatory properties and ability to protect against cell death.

A woman with rheumatoid arthritis lost all her hair during adalimumab treatment, and stopping the drug didn't help.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

Natural products and phytochemicals may help with hair regrowth, but more research is needed.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Fetal skin has unique immune cells different from adult skin.

Alopecia areata is an autoimmune disease with genetic links, treatable with certain medications, and can affect mental health.

Higher levels of certain DNAs in blood may indicate hair follicle damage in alopecia areata patients.

Many people in Saudi Arabia experienced hair loss after COVID-19, especially women, those treated with antivirals, and those with a history of hair shedding.

A protein from fat-derived stem cells, DKK1, is linked to hair loss and blocking it may help treat alopecia areata.

Experts recommend personalized treatment plans for best outcomes in managing Alopecia Areata.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Mutations in the glucocorticoid receptor gene cause reduced sensitivity to glucocorticoids and may lead to poor response to treatment.

The document says that treating burns late focuses on improving function, appearance, and helping patients return to normal life, using both non-surgical and surgical methods.

Some drugs may help treat both COVID-19 and radiation injury.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

Fractional lasers could help hair regrowth in androgenic alopecia, but more research is needed to confirm their effectiveness and safety.

Stem cells and their secretions could potentially treat stress-induced hair loss, but more human trials are needed.

The research suggests immune system changes and specific gene expression may contribute to male hair loss, proposing potential new treatments.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Combination therapies for androgenetic alopecia work best but can have significant side effects and costs.

COVID-19 can cause various skin issues in children, mostly not severe, with chilblain-like lesions being common, especially in adolescents.